BiotechTube

AZD4117 + AZD5315

Phase 1/2Active
0 watching 0 views this week⚡ Active
41
Hype Score

Development Stage

✓
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Influenza A

Conditions

Influenza A

Trial Timeline

Sep 4, 2025 → Dec 29, 2026

NCT ID
NCT07128615

About AZD4117 + AZD5315

AZD4117 + AZD5315 is a phase 1/2 stage product being developed by AstraZeneca for Influenza A. The current trial status is active. This product is registered under clinical trial identifier NCT07128615. Target conditions include Influenza A.

Hype Score Breakdown

Clinical
13
Activity
8
Company
10
Novelty
4
Community
3

Clinical Trials (1)

NCT IDPhaseStatus
NCT07128615Phase 1/2Active

Competing Products

20 competing products in Influenza A

See all competitors
ProductCompanyStageHype Score
Influenza vaccine, split inactivatedComac MedicalPhase 1
25
VaccineComac MedicalPhase 3
69
CT-P27 90 mg/kg + CT-P27 45 mg/kg + PlaceboCelltrionPhase 2
52
CT-P27 + PlaceboCelltrionPhase 2
52
CAIV-TPfizerPhase 3
76
CS-8958 + CS-8958 + oseltamivir phosphateDaiichi SankyoPhase 3
77
Baloxavir Marboxil + Placebo to Baloxavir Marboxil + Oseltamivir + Placebo to OseltamivirShionogiPhase 3
77
Baloxavir Marboxil + Placebo to Baloxavir Marboxil + Oseltamivir + Placebo to OseltamivirShionogiPhase 3
77
fH1 2 ug + fH1 8 ug + DSP-0546LP 2.5 ug + DSP-0546LP 5 ug + DSP-0546LP 10 ug + PlaceboSumitomo PharmaPhase 1
33
Monovalent Influenza VaccineAstraZenecaApproved
85
Monovalent Influenza VaccineAstraZenecaApproved
85
Trivalent Influenza VaccineAstraZenecaApproved
85
Trivalent Influenza VaccineAstraZenecaApproved
85
FluMist trivalent (2015-2016) + FluMist Quadrivalent (2015-2016) + FluMist Quadrivalent (2017-2018)AstraZenecaApproved
85
Trivalent Influenza Virus VaccineAstraZenecaApproved
85
Comparator: Modified Process Vaccine + Comparator: COMVAX™MerckPhase 3
77
Molnupiravir + Placebo molnupiravir + Placebo oseltamivir + Oseltamivir + Influenza A VirusMerckPhase 1
33
V512 + Comparator: Placebo to V512MerckPhase 1
33
Vaxelis + PedvaxHIBMerckApproved
85
Seasonal Influenza VaccineNovartisPhase 2
52

Other Products from AstraZeneca

QuetiapineApproved
85
Dapagliflozin 5 mg + Placebo tabletApproved
85
QuetiapineApproved
85
Ticagrelor + ClopidogrelApproved
85
DurvalumabApproved
85